Premium
Letter: predictive factors for treatment discontinuation in IBD—anti‐TNF trough levels and anti‐drug antibodies
Author(s) -
Demarzo Maria Giulia,
Bodini Giorgia,
Giuliana Elisabetta,
Zentilin Patrizia,
Giannini Edoardo G.
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16494
Subject(s) - medicine , discontinuation , drug , antibody , tumor necrosis factor alpha , immunology , gastroenterology , pharmacology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom